The need for increased clarity and transparency in the regulatory pathway for gene medicines in the European Union

Mol Ther. 2012 Mar;20(3):471-2. doi: 10.1038/mt.2012.14.
No abstract available

Publication types

  • Editorial

MeSH terms

  • European Union
  • Genetic Therapy / legislation & jurisprudence*
  • Genetic Vectors
  • Humans